Here are five points:
1. The Mizuho analysts set a price target of $95 on Amsurg’s stock.
2. Mizuho predicts a potential upside of 20.4 percent from Amsurg’s opening price of $78.88.
3. With a 50-day moving average of $78.60, Amsurg has a 200-day moving average of $77.36.
4. Amsurg stock’s 52-week high is $87.42 and its 52-week low is $54.11.
5. In the past 90 trading days, Amsurg’s share price increased 9.41 points.
More articles on transactions & valuation:
Compass sells Bay Area Physicians Surgery Center following successful turnaround: 5 things to know
Surgery Partners acquires Riverside Pain Physicians; Cantor Fitzgerald analyst claims AmSurg’s latest merger leaves its ASC business’ future hanging in the balance & more — 6 key notes on ASC companies
4 points on Syracuse Orthopedic Specialists meeting patient demand through its orthopedic-driven ASC
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
